Alliance Medical Foundation Liver and Pancreatic Charitable Trust.
( Govt of India Reg )
( Govt of India Reg )
We are the only National charity that offers Free Medical Treatment
support and advice for patients with all forms of Liver & Pancreatic Diseases.
support and advice for patients with all forms of Liver & Pancreatic Diseases.
The kindness of supporters like yourself, enables us
to help people with liver & pancreatic disease.
to help people with liver & pancreatic disease.
About The Charity Visit : www.amftrust.com
Medivir last week announced interim data from the Phase 2b ASPIRE trial, demonstrating that its investigational once-daily HCV protease inhibitor TMC435 (being developed jointly with Tibotec), when combined with pegyalted interferon plus ribavirin, increased the likelihood that treatment-experienced chronic hepatitis C patients would achieve undetectable HCV viral load at 4, 12, and 24 weeks, compared with standard therapy alone. Rates of undetectable HCV RNA at week 24 ranged from 78% for prior null responders to 94% for prior relapsers.
No comments:
Post a Comment